A novel RANKL-targeted selenyl quinolinamide alleviates ovariectomy-induced bone loss through inhibiting ROS, MAPK and NF-κB signaling pathways
Fields of Study & Subjects
Bone Metabolism and Diseases
Selenium in Biological Systems
Bone Tissue Engineering Materials
Publication details
- Journal / source
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Volume
- 305
- Pages
- 118533–118533
- Publication date
- 1 January 2026
- Language
- EN